Hyderabad (Telangana) – Hyderabad based Bharat Biotech and Indian Council of Medical Research (ICMR) together developed a vaccine on Covid-19 in India. Currently this vaccine is being tested for human responses in various 12 institutes across India. Results of the animal trial showed protective efficiency.
ETHealthworld | Animal study proved Covid vaccine's efficacy: Bharat Biotech #Vaccine #Covaxin #AnimalTrials #AnimalTesting #BharatBiotech https://t.co/CXfyVXWkG8
— ETHealthWorld (@ETHealthWorld) September 12, 2020
- For this trial 20 monkeys (rhesus macaques) were divided into 4 groups of 5. They were given the vaccine in 2 doses. A group of monkeys was administered with placebo while three groups were immunised with three different vaccines and then second dose after 14 days.
- All the monkeys were exposed to the virus 14 days after the second dose. The results showed protective efficiency in them. Antibodies against Covid-19 virus were successfully generated. This showed no replication of the virus in the nasal cavity, throat, and lung tissues of the monkeys.
- No evidence of pneumonia was observed by pathological examination in vaccinated groups. Adverse events were not seen in animals immunised with a two-dose vaccination regimen.
The success of this phase of trial of the vaccine is that the animals vaccinated with ‘Covaxin’ developed robust immune system against Covid-19.
Every Indian must watch ‘The Sabarmati Report’ movie : Chief Minister Yogi Adityanath
SC issues notice to Muslim party in Gyanvapi case
Demand to declare Indigenous Cow as Rashtramata
If a relationship with consensual physical intimacy later ends, rape or sexual harassment charges cannot be filed
Special Interview : Efforts like increasing the number of polling stations have led to a rise in voter turnout : S. Chokalingam, Chief Election Officer
Navjot Kaur Sidhu gets new life through Ayurveda; successfully beats stage 4 cancer